Archive · 23 Jul 2026
Trump Announces Tariffs on Imported Generic Drugs
President Trump said that starting in August 2026, there will be no tariffs on imported generic drugs for two years.
After that, the tariffs will go up to 100% for one year and then to 200%.
He wants this to make more generic drugs in the US.
Some people think this is good because it will create jobs, but others worry it will make drugs more expensive.
India, which exports a lot of generic drugs to the US, might be affected by this change.
President Trump announced tariffs on imported generic drugs starting August 2026.
Initial tariff rate will be 0% for two years.
Tariff rate will increase to 100% after two years and 200% thereafter.
Announcement made on Truth Social platform.
Aim is to encourage domestic production of generic drugs.
Indian pharmaceutical stocks fell due to concerns over the impact on exports.
India is a major exporter of generic drugs to the US.
- Who
- US President Donald Trump
- What
- Announcement of tariffs on imported generic drugs
- When
- Tuesday
- Where
- United States
- Why
- To encourage domestic production of generic drugs
Pro-Tariff Perspective
Anti-Tariff Perspective
Economic Impact
Pro-Tariff Perspective
Tariffs will encourage domestic production and create jobs in the pharmaceutical industry.
Anti-Tariff Perspective
Tariffs will increase drug prices and burden consumers and healthcare systems.
Healthcare Access
Pro-Tariff Perspective
Domestic production will ensure a stable supply of generic drugs.
Anti-Tariff Perspective
Higher costs may limit access to affordable medications for many.
- Announcement Date
- Tuesday
- Tariff Start Date
- August 1, 2026
- Initial Tariff Rate
- 0%
- Tariff Rate After Two Years
- 100%
- Tariff Rate After Three Years
- 200%
- Platform Used
- Truth Social
- Impact on Indian Exports
- Potential significant impact on Indian pharmaceutical exports to the US
Sources
Trump Says Imported Generic Drugs To Face 100% Tariff From August 2028
Trump’s generic drug tariff plan: 0% for two years, 100% from 2028 and 200% thereafter
Trump Announces Generic Drug Tariff Plan: 0% For Two Years, 100% From 2028, 200% Thereafter
Trump announces 0% tariffs on generic drugs for 2 years, then 100-200% duties — Impact on India
Trump announces 200% tariff on generic drugs: Here's what it means for 'Pharmacy of the World' India
Sun Pharma, Lupin, and peers in focus after Donald Trump announces generic pharma tariffs timeline
Trump Says Generic Drugs To Face No US Tariffs For 2 Years, Then 100% And 200% Tariffs Later
Another setback to India? Trump says US may impose tariffs upto 200% on generic drug imports. Here's why
Sun Pharma, Aurobindo, Lupin, Zydus Life shares in focus after Trump's 2 year zero tariff on generics
Two-Year Lifeline, Then 200% Tariffs? What Trump's Drug Gamble Means For 'World's Pharmacy' India
Trump announces import tariff up to 200% on generic drugs after 2026 window; India's $9.7bn exports at risk
Trump unveils phased generic drug tariffs
US President Donald Trump Announces Up To 200% Tariffs On Imported Generic Medicines, Threatening India's $9.7 Billion Pharma Exports To US
Nifty pharma slumps nearly 2 pc after Trump announces tariff plan on generic drug imports
Trump announces phased US tariffs on imported generic drugs; Indian pharma stocks fall despite limited impact outlook
Minimal impact on Indian pharma companies supplying medicines to US: Analysts
Pharma stocks fall after Trump’s 200% tariff announcement for generic imports: Experts decode what it means
0% now, 200% later: What Trump’s phased generic drug tariffs mean for India
Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?
Pharma Stocks Slide Up To 3% After Trump Announces 100% Tariff Plan On Generic Drugs
Pharma stocks decline; Aurobindo Pharma down over 4%
Pharma Shares Slide As Trump Targets Generic Drug Imports With New Tariff Plan
Trump announces up to 200% tariff on imported generic drugs from 2028; India pharma exports may face impact
US to Impose Up to 200% Tariffs on Generic Drugs, May Impact India
Indian pharma sees little immediate threat in Trump’s 200% tariff plan
India's pharma takes 'wait-and-watch' approach to tackle Trump's 200% tariff plan
Trump’s tariff threat on generic drugs: Why this matters for Indian pharma companies
Donald Trump Announced 200% Tariffs On Pharma In Upcoming Years
